Rise Advisors’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Rise Advisors’s Portfolio SRRA Stock Details SRRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-250	Closed	-$14K	–	767
2022 Q2	$14K	Hold	250	–	–	0.01%	290
2022 Q1	$8K	Hold	250	–	–	0.01%	365
2021 Q4	$5.43K	Buy	+250	New	+$5.51K	0.01%	401

Other funds holding SRRA

Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Rise Advisors's SRRA Position: Q3 2022 in Review

Rise Advisors sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q3 2022, closing a stake of 250 shares — an estimated $14K sold.

Rise Advisors first reported a position in SRRA in Q4 2021 and held it in 3 quarters. The position peaked at $14K in Q2 2022. 1 fund tracked by Wall St. Rank holds SRRA as of Q3 2022.

Rise Advisors reported no remaining Sierra Oncology, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Rise Advisors sold 250 Sierra Oncology, Inc. Common Stock shares in Q3 2022, an estimated $14K.
Rise Advisors first reported a position in Sierra Oncology, Inc. Common Stock in Q4 2021 and held it in 3 quarters.
Rise Advisors's Sierra Oncology, Inc. Common Stock position peaked at $14K in Q2 2022.
1 fund tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q3 2022.

Based on Rise Advisors's 13F filing for Q3 2022, filed 11 Oct 2022.